Advertisement Applied DNA Sciences and Smiths Detection sign MoU - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Applied DNA Sciences and Smiths Detection sign MoU

Applied DNA Sciences has signed a memorandum of understanding with Smiths Detection, part of the global technology business of Smiths Group.

Under the terms of the agreement, Smiths will provide Applied DNA Sciences (APDN) with exclusive use of the Bio-seeqPLUS platform, centered upon a portable, DNA-verifying device for authentication, anti-counterfeiting and anti-diversion. When used in combination with APDN’s SigNature DNA markers, the Bio-seeq PLUS will provide rapid forensic authentication in the field.

James Hayward, APDN president and CEO stated: “The Bio-seeqPLUS rounds out our three-pronged offering for authenticating originality – nearly instantaneous optical screening, backed up by in-field forensic marker verification, and ultimately supported when required for legal reasons, by in-lab DNA sequencing.”